Show simple item record

dc.contributor.authorKarsen, H.
dc.contributor.authorBinici, I
dc.contributor.authorSünnetçioğlu, Mahmut
dc.contributor.authorBaran, Ali İrfan
dc.contributor.authorCeylan, Melike
dc.contributor.authorSelek, ŞAHBETTİN
dc.contributor.authorCelik, H.
dc.date.accessioned2020-10-29T19:29:55Z
dc.date.available2020-10-29T19:29:55Z
dc.date.issued2012-01-01T00:00:00Z
dc.identifier.urihttp://hdl.handle.net/20.500.12645/25829
dc.description.abstractBackground: The hepatitis B virus is a significant pathogen that causes cirrhosis, and hepatocellular cancer as a result of the damage it causes to liver cells. Its infection affects more than 400 million people globally. Although there is an effective vaccine and treatment methods, almost 1, 000, 000 people die every year.
dc.subjectKarsen H., Binici I., Sünnetçioğlu M., Baran A. İ. , Ceylan M., Selek Ş., Celik H., -Association of paraoxonase activity and atherosclerosis in patients with chronic hepatitis B-, AFRICAN HEALTH SCIENCES, cilt.12, ss.114-118, 2012
dc.titleAssociation of paraoxonase activity and atherosclerosis in patients with chronic hepatitis B
dc.typeArticle
dc.identifier.wosWOS:000315184900006
dc.identifier.scopus84864374667
dc.identifier.doi10.4314/ahs.v12i2.6
dc.identifier.pubmed23056015
local.publication.isinternational1


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record